Nasal Drug Delivery Technologies Market by Dosage Form (Nasal Sprays, Drops & Liquids, Powders, Gels, and Others), Container (Pressurized Containers and Non-pressurized Containers), System (Multi-dose Systems, Bi-dose Systems, Unit-dose Systems), Therapeutic Applications (Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination, and Others), and End User (Home Care Settings and Hospitals) - Global Opportunity Analysis and Industry Forecast, 2020-2027
|
LI_182588
|
Pages: NA
|
Mar 2020 |
2041 Views
|
|
|
|
Author(s) :
NA
|
Tables: NA
|
Charts: NA
|
Formats*:
|
|
Nasal delivery is used as a treatment of local infection in the nasal course & paranasal sinuses such as allergic & non-allergic sinusitis & rhinitis. The nasal drug delivery technique is used as to mitigate the problem of slow absorption of drugs, degradation before reaching the target site, and poor bioavailability. In addition, it helps in resolving issues related to the gastrointestinal tract and first-pass metabolism in liver. The significance of the nasal airway technology is to protect the lungs from hazardous contacts, rather than acting as a delivery route for drugs.
The global nasal drug delivery technology market is driven by rise in demand for alternative routes of drug delivery such as nasal sprays, increase in emphasis on pediatric & geriatric patients, growth in need of easy administration & better efficacy products, rise in demand for home healthcare devices, surge in adoption of self-administration practices, and advanced healthcare set-up. However, patents expiry of several drugs and side effects pertaining to drugs, such as nausea, irritation, and infections, restrain the market growth. Conversely, the development of OTC drugs by many pharmaceutical companies provides lucrative opportunities for market growth, especially for nasal drops and sprays sold as generic OTC drugs.
The global nasal drug delivery technology market is segmented on the basis of dosage form, container, system, therapeutic application, end user, and region. Based on dosage form, it is categorized into sprays, drops & liquids, powders, gels, and others. On the basis of container, it is bifurcated into pressurized containers and non-pressurized containers. Based on system, it is divided into multi-dose systems, bi-dose systems, and unit-dose systems. Based on therapeutic application, it is classified into allergic & non-allergic rhinitis, nose congestion, vaccination, and others. Based on end user, it is divided into home care settings and hospitals. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in this market include Merck & Co., Inc., Novartis AG, Johnson & Johnson, Pfizer Inc., AstraZeneca, AptarGroup, Inc., GlaxoSmithKline plc., Aegis Therapeutics LLC., and Becton, Dickinson and Company.
Key Benefits
- The report presents the market analysis of the global nasal drug delivery technology market along with the regional trends and future estimations.
- It provides extensive information about the market segments from 2016 to 2023 to understand the market dynamics.
- The key factors that drive, hamper, or provide opportunities to the market are provided in the report
- Competitive landscape of the industry along with the profile analysis of market players is provided in the report.
Nasal Drug Delivery Technologies Market Key Segments
By Dosage Form
- Sprays
- Drops & Liquids
- Powders
- Gels
- Others
By Container
- Pressurized Containers
- Non-pressurized Containers
By System
- Multi-dose Systems
- Bi-dose Systems
- Unit-dose Systems
By Therapeutic Applications
- Allergic & Non-allergic Rhinitis
- Nose Congestion
- Vaccination
- Others
By End User
- Home Care Settings
- Hospitals
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. TOP PLAYER POSITIONING/MARKET SHARE ANALYSIS, 2016
3.4. PATENT ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 NASAL DRUG DELIVERY TECHNOLOGIES MARKET, BY DOSAGE FORM
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. NASAL SPRAYS
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. DROPS & LIQUIDS
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. POWDERS
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. GELS
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
CHAPTER 5 NASAL DRUG DELIVERY TECHNOLOGIES MARKET, BY CONTAINER
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. PRESSURIZED CONTAINERS
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. NON-PRESSURIZED CONTAINERS
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
CHAPTER 6 NASAL DRUG DELIVERY TECHNOLOGIES MARKET, BY SYSTEM
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. MULTI-DOSE SYSTEMS
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. BI-DOSE SYSTEMS
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. UNIT-DOSE SYSTEMS
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
CHAPTER 7 NASAL DRUG DELIVERY TECHNOLOGIES MARKET, BY THERAPEUTIC APPLICATION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. ALLERGIC & NON-ALLERGIC RHINITIS
7.2.1. Market size and forecast, by region
7.2.2. Market analysis, by country
7.3. NOSE CONGESTION
7.3.1. Market size and forecast, by region
7.3.2. Market analysis, by country
7.4. VACCINATION
7.4.1. Market size and forecast, by region
7.4.2. Market analysis, by country
7.5. OTHER THERAPEUTIC APPLICATIONS
7.5.1. Market size and forecast, by region
7.5.2. Market analysis, by country
CHAPTER 8 NASAL DRUG DELIVERY TECHNOLOGIES MARKET, BY END USER
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. HOME CARE SETTINGS
8.2.1. Market size and forecast, by region
8.2.2. Market analysis, by country
8.3. HOSPITALS & CLINICS
8.3.1. Market size and forecast, by region
8.3.2. Market analysis, by country
CHAPTER 9 NASAL DRUG DELIVERY TECHNOLOGIES MARKET, BY REGION
9.1. OVERVIEW
9.2. NORTH AMERICA
9.2.1. Key market trends, growth factors and opportunities
9.2.2. North America nasal drug delivery technologies market, by country
9.2.2.1. U.S. nasal drug delivery technologies market
9.2.2.1.1. U.S. market, by dosage form
9.2.2.1.2. U.S. market, by container
9.2.2.1.3. U.S. market, by system
9.2.2.1.4. U.S. market, by therapeutic application
9.2.2.1.5. U.S. market, by end user
9.2.2.2. Canada nasal drug delivery technologies market
9.2.2.2.1. Canada market, by dosage form
9.2.2.2.2. Canada market, by container
9.2.2.2.3. Canada market, by system
9.2.2.2.4. Canada market, by therapeutic application
9.2.2.2.5. Canada market, by end user
9.2.2.3. Mexico nasal drug delivery technologies market
9.2.2.3.1. Mexico market, by dosage form
9.2.2.3.2. Mexico market, by container
9.2.2.3.3. Mexico market, by system
9.2.2.3.4. Mexico market, by therapeutic application
9.2.2.3.5. Mexico market, by end user
9.2.3. North America nasal drug delivery technologies market, by dosage form
9.2.4. North America nasal drug delivery technologies market, by container
9.2.5. North America nasal drug delivery technologies market, by system
9.2.6. North America nasal drug delivery technologies market, by therapeutic application
9.2.7. North America nasal drug delivery technologies market, by end user
9.3. EUROPE
9.3.1. Key market trends, growth factors and opportunities
9.3.2. Europe nasal drug delivery technologies market, by country
9.3.2.1. Germany nasal drug delivery technologies market
9.3.2.1.1. Germany market, by dosage form
9.3.2.1.2. Germany market, by container
9.3.2.1.3. Germany market, by system
9.3.2.1.4. Germany market, by therapeutic application
9.3.2.1.5. Germany market, by end user
9.3.2.2. France nasal drug delivery technologies market
9.3.2.2.1. France market, by dosage form
9.3.2.2.2. France market, by container
9.3.2.2.3. France market, by system
9.3.2.2.4. France market, by therapeutic application
9.3.2.2.5. France market, by end user
9.3.2.3. UK nasal drug delivery technologies market
9.3.2.3.1. UK market, by dosage form
9.3.2.3.2. UK market, by container
9.3.2.3.3. UK market, by system
9.3.2.3.4. UK market, by therapeutic application
9.3.2.3.5. UK market, by end user
9.3.2.4. Italy nasal drug delivery technologies market
9.3.2.4.1. Italy market, by dosage form
9.3.2.4.2. Italy market, by container
9.3.2.4.3. Italy market, by system
9.3.2.4.4. Italy market, by therapeutic application
9.3.2.4.5. Italy market, by end user
9.3.2.5. Spain nasal drug delivery technologies market
9.3.2.5.1. Spain market, by dosage form
9.3.2.5.2. Spain market, by container
9.3.2.5.3. Spain market, by system
9.3.2.5.4. Spain market, by therapeutic application
9.3.2.5.5. Spain market, by end user
9.3.2.6. Rest of Europe nasal drug delivery technologies market
9.3.2.6.1. Rest of Europe market, by dosage form
9.3.2.6.2. Rest of Europe market, by container
9.3.2.6.3. Rest of Europe market, by system
9.3.2.6.4. Rest of Europe market, by therapeutic application
9.3.2.6.5. Rest of Europe market, by end user
9.3.3. Europe nasal drug delivery technologies market, by dosage form
9.3.4. Europe nasal drug delivery technologies market, by container
9.3.5. Europe nasal drug delivery technologies market, by system
9.3.6. Europe nasal drug delivery technologies market, by therapeutic application
9.3.7. Europe nasal drug delivery technologies market, by end user
9.4. ASIA-PACIFIC
9.4.1. Key market trends, growth factors and opportunities
9.4.2. Asia-Pacific nasal drug delivery technologies market, by country
9.4.2.1. Japan nasal drug delivery technologies market
9.4.2.1.1. Japan market, by dosage form
9.4.2.1.2. Japan market, by container
9.4.2.1.3. Japan market, by system
9.4.2.1.4. Japan market, by therapeutic application
9.4.2.1.5. Japan market, by end user
9.4.2.2. China nasal drug delivery technologies market
9.4.2.2.1. China market, by dosage form
9.4.2.2.2. China market, by container
9.4.2.2.3. China market, by system
9.4.2.2.4. China market, by therapeutic application
9.4.2.2.5. China market, by end user
9.4.2.3. Australia nasal drug delivery technologies market
9.4.2.3.1. Australia market, by dosage form
9.4.2.3.2. Australia market, by container
9.4.2.3.3. Australia market, by system
9.4.2.3.4. Australia market, by therapeutic application
9.4.2.3.5. Australia market, by end user
9.4.2.4. India nasal drug delivery technologies market
9.4.2.4.1. India market, by dosage form
9.4.2.4.2. India market, by container
9.4.2.4.3. India market, by system
9.4.2.4.4. India market, by therapeutic application
9.4.2.4.5. India market, by end user
9.4.2.5. South Korea nasal drug delivery technologies market
9.4.2.5.1. South Korea market, by dosage form
9.4.2.5.2. South Korea market, by container
9.4.2.5.3. South Korea market, by system
9.4.2.5.4. South Korea market, by therapeutic application
9.4.2.5.5. South Korea market, by end user
9.4.2.6. Rest of Asia-Pacific nasal drug delivery technologies market
9.4.2.6.1. Rest of Asia-Pacific market, by dosage form
9.4.2.6.2. Rest of Asia-Pacific market, by container
9.4.2.6.3. Rest of Asia-Pacific market, by system
9.4.2.6.4. Rest of Asia-Pacific market, by therapeutic application
9.4.2.6.5. Rest of Asia-Pacific market, by end user
9.4.3. Asia-Pacific nasal drug delivery technologies market, by dosage form
9.4.4. Asia-Pacific nasal drug delivery technologies market, by container
9.4.5. Asia-Pacific nasal drug delivery technologies market, by system
9.4.6. Asia-Pacific nasal drug delivery technologies market, by therapeutic application
9.4.7. Asia-Pacific nasal drug delivery technologies market, by end user
9.5. LAMEA
9.5.1. Key market trends, growth factors and opportunities
9.5.2. LAMEA nasal drug delivery technologies market, by country
9.5.2.1. Brazil nasal drug delivery technologies market
9.5.2.1.1. Brazil market, by dosage form
9.5.2.1.2. Brazil market, by container
9.5.2.1.3. Brazil market, by system
9.5.2.1.4. Brazil market, by therapeutic application
9.5.2.1.5. Brazil market, by end user
9.5.2.2. Saudi Arabia nasal drug delivery technologies market
9.5.2.2.1. Saudi Arabia market, by dosage form
9.5.2.2.2. Saudi Arabia market, by container
9.5.2.2.3. Saudi Arabia market, by system
9.5.2.2.4. Saudi Arabia market, by therapeutic application
9.5.2.2.5. Saudi Arabia market, by end user
9.5.2.3. South Africa nasal drug delivery technologies market
9.5.2.3.1. South Africa market, by dosage form
9.5.2.3.2. South Africa market, by container
9.5.2.3.3. South Africa market, by system
9.5.2.3.4. South Africa market, by therapeutic application
9.5.2.3.5. South Africa market, by end user
9.5.2.4. Rest of LAMEA nasal drug delivery technologies market
9.5.2.4.1. Rest of LAMEA market, by dosage form
9.5.2.4.2. Rest of LAMEA market, by container
9.5.2.4.3. Rest of LAMEA market, by system
9.5.2.4.4. Rest of LAMEA market, by therapeutic application
9.5.2.4.5. Rest of LAMEA market, by end user
9.5.3. LAMEA nasal drug delivery technologies market, by dosage form
9.5.4. LAMEA nasal drug delivery technologies market, by container
9.5.5. LAMEA nasal drug delivery technologies market, by system
9.5.6. LAMEA nasal drug delivery technologies market, by therapeutic application
9.5.7. LAMEA nasal drug delivery technologies market, by end user
CHAPTER 10 COMPANY PROFILES
10.1. MERCK & CO., INC.
10.1.1. Operating business segments
10.1.2. Business performance
10.1.3. Key strategic moves and developments
10.2. NOVARTIS AG
10.2.1. Operating business segments
10.2.2. Business performance
10.2.3. Key strategic moves and developments
10.3. JOHNSON & JOHNSON
10.3.1. Operating business segments
10.3.2. Business performance
10.3.3. Key strategic moves and developments
10.4. PFIZER, INC.
10.4.1. Operating business segments
10.4.2. Business performance
10.4.3. Key strategic moves and developments
10.5. ASTRAZENECA PLC.
10.5.1. Operating business segments
10.5.2. Business performance
10.5.3. Key strategic moves and developments
10.6. APTARGROUP INC.
10.6.1. Operating business segments
10.6.2. Business performance
10.6.3. Key strategic moves and developments
10.7. GLAXOSMITHKLINE PLC.
10.7.1. Operating business segments
10.7.2. Business performance
10.7.3. Key strategic moves and developments
10.8. AEGIS THERAPEUTICS LLC
10.8.1. Operating business segments
10.8.2. Business performance
10.8.3. Key strategic moves and developments
10.9. BECTON, DICKINSON AND COMPANY
10.9.1. Operating business segments
10.9.2. Business performance
10.9.3. Key strategic moves and developments
10.10. 3M COMPANY
10.10.1. Operating business segments
10.10.2. Business performance
10.10.3. Key strategic moves and developments
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
REQUEST TOC/SAMPLE
Purchase Full Report of
Nasal Drug Delivery Technologies Market- Global Opportunity Analysis and Industry Forecast, 2020-2027
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5,370$4,833 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $0.00
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. Subscription @ $559 T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.